Jason B Dinoso
Overview
Explore the profile of Jason B Dinoso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutierrez J, Guimaraes A, Lewin-Koh N, Berhanu A, Xu M, Cao Y, et al.
Open Forum Infect Dis
. 2019 Apr;
6(4):ofz090.
PMID: 31024970
Background: (SA) bacteremia often requires a long treatment duration with antibiotics to prevent relapse due to the ability of SA to establish reservoirs of infection in sites such as heart...
2.
Guimaraes A, Cao Y, Hong K, Mayba O, Peck M, Gutierrez J, et al.
Clin Infect Dis
. 2018 Aug;
68(9):1502-1511.
PMID: 30165412
Background: Staphylococcus aureus is a leading cause of bacteremia, yet there remains a significant knowledge gap in the identification of relevant biomarkers that predict clinical outcomes. Heterogeneity in the host...
3.
Queen S, Mears B, Kelly K, Dorsey J, Liao Z, Dinoso J, et al.
J Virol
. 2011 Jul;
85(17):9167-75.
PMID: 21715484
In response to pressure exerted by major histocompatibility complex (MHC) class I-mediated CD8(+) T cell control, human immunodeficiency virus (HIV) escape mutations often arise in immunodominant epitopes recognized by MHC...
4.
Gaillard S, Dinoso J, Marsh J, DeZern A, OConnell K, Spivak A, et al.
J Clin Virol
. 2011 May;
51(3):195-8.
PMID: 21550842
The mechanism of elite control of HIV-1 replication is not fully understood. While immunosuppression due to rituximab based chemotherapy has been associated with increased replication of HBV, CMV, and HIV-1,...
5.
OConnell K, Pelz R, Dinoso J, Dunlop E, Paik-Tesch J, Williams T, et al.
AIDS Res Hum Retroviruses
. 2010 Sep;
26(12):1307-11.
PMID: 20854198
The HLA-B*27 allele is overrepresented in patients who control HIV-1 replication without antiretroviral therapy. CD8(+) T cell responses that target the immunodominant KK10 epitope in Gag are thought to play...
6.
Margolick J, Imteyaz H, Gallant J, Langan S, Dinoso J, Siliciano J, et al.
AIDS
. 2010 Mar;
24(6):932-5.
PMID: 20234195
No abstract available.
7.
Sedaghat A, Rastegar D, OConnell K, Dinoso J, Wilke C, Blankson J
Clin Infect Dis
. 2009 Oct;
49(11):1763-6.
PMID: 19857162
Elite controllers or suppressors are untreated human immunodeficiency virus type 1 (HIV-1)-infected patients who maintain undetectable viral loads. In this study, we show that most elite suppressors do not experience...
8.
Dinoso J, Rabi S, Blankson J, Gama L, Mankowski J, Siliciano R, et al.
J Virol
. 2009 Jul;
83(18):9247-57.
PMID: 19570871
The treatment of human immunodeficiency virus type 1 (HIV-1) infection with highly active antiretroviral therapy (HAART), a combination of three or more antiretroviral drugs, suppresses viremia below the clinical limit...
9.
Dinoso J, Kim S, Siliciano R, Blankson J
Clin Infect Dis
. 2008 May;
47(1):102-4.
PMID: 18494606
Elite suppressors are untreated individuals with human immunodeficiency virus type 1 (HIV-1) infection who maintain viral loads <50 copies/mL. Using a single-copy assay, we show that there is no statistically...
10.
Sedaghat A, Dinoso J, Shen L, Wilke C, Siliciano R
Proc Natl Acad Sci U S A
. 2008 Mar;
105(12):4832-7.
PMID: 18362342
The time to suppression of HIV-1 viremia to below the limit of detection of standard clinical assays is an important prognostic indicator for patients on highly active antiretroviral therapy (HAART)....